drugset / Trial / NCT00448955

Open-Label Study of ARD-0403 in Testosterone Deficient Men

NCT00448955 ↗

Phase 3 Completed 150 enrolled Ardana Bioscience Ltd
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Male hypogonadism, a disorder associated with testosterone deficiency, is frequently seen in clinical practice and has significant effects on patient wellbeing. The purpose of this study is to investigate the efficacy and safety of ARD-0403 as a testosterone replacement therapy in testosterone deficient men.

Timeline

Start
2007-05
Primary completion
2008-02
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Subject ARD-0403 Unknown — —

Indications